UNIGE document Scientific Article
previous document  unige:7275  next document
add to browser collection
Title

Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients

Authors
Glass, T. R.
De Geest, Sabina
Battegay, Manuel
Furrer, Hansjakob
Covassini, Matthias
Vernazza, P. L.
show hidden authors show all authors [1 - 11]
Published in Antiviral Therapy. 2008, vol. 13, no. 1, p. 77-85
Abstract BACKGROUND: The aim of this study was to explore the predictive value of longitudinal self-reported adherence data on viral rebound. METHODS: Individuals in the Swiss HIV Cohort Study on combined antiretroviral therapy (cART) with RNA <50 copies/ml over the previous 3 months and who were interviewed about adherence at least once prior to 1 March 2007 were eligible. Adherence was defined in terms of missed doses of cART (0, 1, 2 or >2) in the previous 28 days. Viral rebound was defined as RNA >500 copies/ml. Cox regression models with time-independent and -dependent covariates were used to evaluate time to viral rebound. RESULTS: A total of 2,664 individuals and 15,530 visits were included. Across all visits, missing doses were reported as follows: 1 dose 14.7%, 2 doses 5.1%, >2 doses 3.8% taking <95% of doses 4.5% and missing > or =2 consecutive doses 3.2%. In total, 308 (11.6%) patients experienced viral rebound. After controlling for confounding variables, self-reported non-adherence remained significantly associated with the rate of occurrence of viral rebound (compared with zero missed doses: 1 dose, hazard ratio [HR] 1.03, 95% confidence interval [CI] 0.72-1.48; 2 doses, HR 2.17, 95% CI 1.46-3.25; >2 doses, HR 3.66, 95% CI 2.50-5.34). Several variables significantly associated with an increased risk of viral rebound irrespective of adherence were identified: being on a protease inhibitor or triple nucleoside regimen (compared with a non-nucleoside reverse transcriptase inhibitor), >5 previous cART regimens, seeing a less-experienced physician, taking co-medication, and a shorter time virally suppressed. CONCLUSIONS: A simple self-report adherence questionnaire repeatedly administered provides a sensitive measure of non-adherence that predicts viral rebound.
Keywords AdultAnti-HIV Agents/ administration & dosage/ therapeutic useCohort StudiesFemaleHIV Infections/ diagnosis/ drug therapy/virologyHIV-1/ drug effects/isolation & purification/physiologyHumansInterviews as TopicLongitudinal StudiesMaleMiddle AgedPatient CompliancePrognosisReproducibility of ResultsSelf DisclosureTreatment Failure
Identifiers
PMID: 18389901
Full text
Structures
Citation
(ISO format)
GLASS, T. R. et al. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. In: Antiviral Therapy, 2008, vol. 13, n° 1, p. 77-85. https://archive-ouverte.unige.ch/unige:7275

187 hits

0 download

Update

Deposited on : 2010-06-21

Export document
Format :
Citation style :